These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26618552)
1. Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2. Guo Y; Zhang Y; Yang X; Lu P; Yan X; Xiao F; Zhou H; Wen C; Shi M; Lu J; Meng QH Cancer Biol Ther; 2016; 17(2):169-80. PubMed ID: 26618552 [TBL] [Abstract][Full Text] [Related]
2. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2. Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916 [TBL] [Abstract][Full Text] [Related]
3. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo. Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383 [TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway. Chen Y; Fang L; Li G; Zhang J; Li C; Ma M; Guan C; Bai F; Lyu J; Meng QH Oncotarget; 2017 Aug; 8(33):54838-54857. PubMed ID: 28903386 [TBL] [Abstract][Full Text] [Related]
5. Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells. Noh EM; Lee YR; Hong OY; Jung SH; Youn HJ; Kim JS Oncol Rep; 2015 Aug; 34(2):803-10. PubMed ID: 26044736 [TBL] [Abstract][Full Text] [Related]
6. Glyoxalase I gene deletion mutants of Leishmania donovani exhibit reduced methylglyoxal detoxification. Chauhan SC; Madhubala R PLoS One; 2009 Aug; 4(8):e6805. PubMed ID: 19710909 [TBL] [Abstract][Full Text] [Related]
7. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells. Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983 [TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of ΔFosB on proliferation and apoptosis of MCF-7 breast cancer cells. Li H; Li L; Zheng H; Yao X; Zang W Tumour Biol; 2016 May; 37(5):6053-63. PubMed ID: 26608367 [TBL] [Abstract][Full Text] [Related]
9. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Nokin MJ; Bellier J; Durieux F; Peulen O; Rademaker G; Gabriel M; Monseur C; Charloteaux B; Verbeke L; van Laere S; Roncarati P; Herfs M; Lambert C; Scheijen J; Schalkwijk C; Colige A; Caers J; Delvenne P; Turtoi A; Castronovo V; Bellahcène A Breast Cancer Res; 2019 Jan; 21(1):11. PubMed ID: 30674353 [TBL] [Abstract][Full Text] [Related]
10. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression. Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y J Obstet Gynaecol Res; 2012 Aug; 38(8):1077-85. PubMed ID: 22540333 [TBL] [Abstract][Full Text] [Related]
11. Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules. Taniguchi H; Horinaka M; Yoshida T; Yano K; Goda AE; Yasuda S; Wakada M; Sakai T Mol Cancer Ther; 2012 Oct; 11(10):2294-300. PubMed ID: 22784708 [TBL] [Abstract][Full Text] [Related]
12. Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells. Park SH; Kim JH; Lee DH; Kang JW; Song HH; Oh SR; Yoon DY Biochimie; 2013 Nov; 95(11):2082-90. PubMed ID: 23933110 [TBL] [Abstract][Full Text] [Related]
13. Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion. Seol MA; Park JH; Jeong JH; Lyu J; Han SY; Oh SM Oncotarget; 2017 Jun; 8(25):40190-40203. PubMed ID: 28212583 [TBL] [Abstract][Full Text] [Related]
14. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis. Yang XL; Liu KY; Lin FJ; Shi HM; Ou ZL Oncol Rep; 2017 Sep; 38(3):1393-1401. PubMed ID: 28713975 [TBL] [Abstract][Full Text] [Related]
15. Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression. Jiang Y; Chen X; Wei Y; Feng Y; Zheng W; Zhang Z Biomed Pharmacother; 2019 May; 113():108712. PubMed ID: 30849641 [TBL] [Abstract][Full Text] [Related]
16. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells. Shen YY; Yuan Y; Du YY; Pan YY Mol Med Rep; 2015 Jul; 12(1):623-30. PubMed ID: 25738368 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous Caspases. Fan S; Xu H; Liu H; Hu Z; Xiao J; Liu H J BUON; 2019; 24(4):1532-1537. PubMed ID: 31646804 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1. Bhowmik T; Gomes A Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778 [TBL] [Abstract][Full Text] [Related]
20. Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation. Jang SY; Lee JK; Jang EH; Jeong SY; Kim JH Oncol Rep; 2014 Jun; 31(6):2827-33. PubMed ID: 24789371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]